Tg Therapeutics (TGTX) Leases (2019 - 2025)
Historic Leases for Tg Therapeutics (TGTX) over the last 7 years, with Q3 2025 value amounting to $6.5 million.
- Tg Therapeutics' Leases fell 1227.9% to $6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 million, marking a year-over-year decrease of 1227.9%. This contributed to the annual value of $7.2 million for FY2024, which is 1116.77% down from last year.
- According to the latest figures from Q3 2025, Tg Therapeutics' Leases is $6.5 million, which was down 1227.9% from $6.7 million recorded in Q2 2025.
- Tg Therapeutics' Leases' 5-year high stood at $9.1 million during Q1 2021, with a 5-year trough of $6.5 million in Q3 2025.
- Moreover, its 5-year median value for Leases was $8.5 million (2023), whereas its average is $8.2 million.
- In the last 5 years, Tg Therapeutics' Leases skyrocketed by 336.21% in 2022 and then crashed by 1238.3% in 2025.
- Quarter analysis of 5 years shows Tg Therapeutics' Leases stood at $8.6 million in 2021, then grew by 3.0% to $8.9 million in 2022, then decreased by 9.43% to $8.0 million in 2023, then decreased by 11.17% to $7.2 million in 2024, then fell by 9.09% to $6.5 million in 2025.
- Its last three reported values are $6.5 million in Q3 2025, $6.7 million for Q2 2025, and $6.9 million during Q1 2025.